Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer

Up to now, the efficacy of programmed death protein 1/programmed death ligand 1 (PD-1/PD-L1) blockade in pancreatic cancer (PC) remains uncertain. Serum levels of soluble PD-1 and PD-L1 (sPD-1/sPD-L1) have been reported to be independent prognostic factors in solid tumors susceptible to checkpoint b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stephan Kruger, Marie-Louise Legenstein, Verena Rösgen, Michael Haas, Dominik Paul Modest, Christoph Benedikt Westphalen, Steffen Ormanns, Thomas Kirchner, Volker Heinemann, Stefan Holdenrieder, Stefan Boeck
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis Group 2017-05-01
Colecção:OncoImmunology
Assuntos:
immunotherapy
soluble programmed death ligand 1
soluble programmed cell death protein 1
pancreatic cancer
tumor marker
Acesso em linha:http://dx.doi.org/10.1080/2162402X.2017.1310358
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados